These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16442270)

  • 1. ECNP consensus meeting March 2003 guidelines for the investigation of efficacy in substance use disorders.
    Van den Brink W; Montgomery SA; Van Ree JM; van Zwieten-Boot BJ;
    Eur Neuropsychopharmacol; 2006 Apr; 16(3):224-30. PubMed ID: 16442270
    [No Abstract]   [Full Text] [Related]  

  • 2. ECNP Consensus Meeting, March 2003. Guidelines for the investigation of efficacy in social anxiety disorder.
    Montgomery SA; Lecrubier Y; Baldwin DS; Kasper S; Lader M; Nil R; Stein D; Van Ree JM;
    Eur Neuropsychopharmacol; 2004 Oct; 14(5):425-33. PubMed ID: 15336305
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatments for patients with dual diagnosis: a review.
    Tiet QQ; Mausbach B
    Alcohol Clin Exp Res; 2007 Apr; 31(4):513-36. PubMed ID: 17374031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of comorbid bipolar disorder and substance abuse.
    Vornik LA; Brown ES
    J Clin Psychiatry; 2006; 67 Suppl 7():24-30. PubMed ID: 16961421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some new directions for research on psychological interventions for comorbid anxiety and substance use disorders.
    Baillie AJ; Stapinski L; Crome E; Morley K; Sannibale C; Haber P; Teesson M
    Drug Alcohol Rev; 2010 Sep; 29(5):518-24. PubMed ID: 20887575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attrition in substance abuse comparative treatment research: the illusion of randomization.
    Howard KI; Cox WM; Saunders SM
    NIDA Res Monogr; 1990; 104():66-79. PubMed ID: 2092226
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancing the validity and utility of randomized clinical trials in addictions treatment research: I. Treatment implementation and research design.
    Del Boca FK; Darkes J
    Addiction; 2007 Jul; 102(7):1047-56. PubMed ID: 17567393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study.
    Swartz MS; Wagner HR; Swanson JW; Stroup TS; McEvoy JP; Canive JM; Miller DD; Reimherr F; McGee M; Khan A; Van Dorn R; Rosenheck RA; Lieberman JA
    J Nerv Ment Dis; 2006 Mar; 194(3):164-72. PubMed ID: 16534433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual diagnosis and psychosocial interventions--introduction and commentary.
    Thylstrup B; Johansen KS
    Nord J Psychiatry; 2009; 63(3):202-8. PubMed ID: 19034725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-occurring substance dependence and depression: practical implications and next questions.
    McKay JR
    Addiction; 2005 Dec; 100(12):1755-7. PubMed ID: 16367973
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical challenges in the treatment of patients with posttraumatic stress disorder and substance abuse.
    Schäfer I; Najavits LM
    Curr Opin Psychiatry; 2007 Nov; 20(6):614-8. PubMed ID: 17921765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
    Horsfall J; Cleary M; Hunt GE; Walter G
    Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECNP consensus meeting. Negative, depressive and cognitive symptoms of schizophrenia. Nice, March 2004.
    Montgomery SA; van Zwieten-Boot B
    Eur Neuropsychopharmacol; 2007 Jan; 17(1):70-7. PubMed ID: 16842980
    [No Abstract]   [Full Text] [Related]  

  • 16. Eating disorders and substance use: be aware of this dual diagnosis.
    Wandler K
    Behav Healthc Tomorrow; 2003 Dec; 12(6):8, 11. PubMed ID: 14696288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use and psychosis.
    Pawsey B; Castle D
    Aust Fam Physician; 2006 Mar; 35(3):110-2. PubMed ID: 16525520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials in drug treatment: methodology.
    Hall SM
    NIDA Res Monogr; 1984; 51():88-105. PubMed ID: 6438520
    [No Abstract]   [Full Text] [Related]  

  • 19. Spiritual guidance, addiction treatment, and long-term recovery.
    White WL
    J Subst Abuse Treat; 2008 Dec; 35(4):443-4. PubMed ID: 18657939
    [No Abstract]   [Full Text] [Related]  

  • 20. The status of addiction treatment research with co-occurring substance use and psychiatric disorders.
    McGovern MP; McLellan AT
    J Subst Abuse Treat; 2008 Jan; 34(1):1-2. PubMed ID: 17574797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.